Introduction The introduction to the Canadian market of three new drugs for the management of Parkinson’s disease (PD) in the last 2 years (one of which has been withdrawn due to rare hepatic... Read More

 Introduction Parkinson's disease (PD) affects people of all ages. Although 20% may be diagnosed under the age of 50, the usual age of onset is between the sixth and eighth decades. With the... Read More

Introduction The management of Parkinson’s disease (PD) today is a complex and demanding task as more treatment options become available. The patient often poses challenging problems, which may be... Read More

 Introduction There are between 5000 and 8000 British Columbians with Parkinson's disease (PD). The vast majority of them are well treated with the medications outlined elsewhere in this... Read More

Introduction Parkinson's disease is commonly associated with psychiatric morbidity, which includes depression, anxiety, and dopaminergic psychosis. These compound the patient's predicament.... Read More